Ilumya

Ilumya Infusion Therapy Modesto CA

Ilumya

ILUMYA is an interleukin-23 antagonist indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

Administration Information

It is given as a subcutaneous injection at Weeks 0, 4, and every twelve weeks thereafter

Initial Doses - Week 0 & 4
0
Then Every 12 Weeks Thereafter
0

Potential Side Effects

In clinical studies, the following adverse reactions were reported in at least 5% of subjects receiving Zemaira: headache, sinusitis, upper respiratory infection, bronchitis, fatigue, increased cough, fever, injection-site bleeding, nasal symptoms, sore throat, and swelled blood vessels.

 

For a full list of potential side effects, please see the Important Safety Information and Medication Guide on the Zemaira website.

Patient Forms

Before you attend your first appointment at Omega Health, please make sure to review the documents below. The Patient Consent Form and HIPAA Privacy Authorization Form need to be filled out and signed ahead of your appointment, whereas the Notice of Privacy Practices and Patient Rights and Responsibilities are for reference only. Please contact us if you have any questions!

Patient Consent Form

Print & Sign

HIPAA Privacy Authorization Form

Print & Sign

Notice of Privacy Practice

Read

Patient Rights and Responsibilities

Read

Appointment Lateness and Cancelation

Read

The Omega Health Clinics Experience

We offer expert infusion therapy without the hassle or cost of the hospital. We employ highly trained medical staff that work with health insurance companies & physicians to provide our patients with convenient care.

At Omega Health Clinics, we’re committed to offering affordable treatment, with upfront pricing and no hidden costs. Here’s how we make it happen.